Neoadjuvant Chemotherapy for Initially Resectable Metachronous Colorectal Cancer Liver Metastases Is Associated With Early Postoperative Relapse
Routine NAC for initially resectable metachronous CRCLM should be avoided because of the high risk of early relapse.
Authors
- Hideo Wada (ORCID: https://orcid.org/0000-0001-9021-8633)
- Daijiro Higashi (ORCID: https://orcid.org/0000-0003-1865-665X)
- Makoto Kawamoto (ORCID: https://orcid.org/0000-0002-5488-7933)
- Hiroyuki Takahashi (ORCID: https://orcid.org/0000-0001-7003-5151)
- Hiroki Kaida
- Yoshihiro Miyasaka (ORCID: https://orcid.org/0000-0003-4344-4448)
- Kosuke Horinouchi
- Masato Watanabe (ORCID: https://orcid.org/0009-0001-4152-0454)
- Daibo Kojima (ORCID: https://orcid.org/0000-0001-5388-8320)
- K Hanaoka
Institutions
- Fukuoka University (JP)
Publication Details
- Journal
- Anticancer Research
- Published
- 2025-09-26
- DOI
- https://doi.org/10.21873/anticanres.17801
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00